| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/09/2010 | CN101167789B Tumor recovering capsule and production method thereof |
| 06/09/2010 | CN101164586B Medicinal composition for treating sexual impotence and preparation process thereof |
| 06/09/2010 | CN101152492B Chinese medicine preparations for enlivening the spleen and strengthening vital energy of kidney, and method for preparing the same |
| 06/09/2010 | CN101152365B Chinese medicinal herb pill for treating hepatitis b |
| 06/09/2010 | CN101130013B Traditional Chinese medicine composition for treating ulcer of stomach and duodenum, and method of preparing the same |
| 06/09/2010 | CN101129948B Pharmaceutical composition for treating gynecology hysteromyoma and processes for producing same |
| 06/09/2010 | CN101129823B Orally taken traditional Chinese medicine composition for treating anaphylactoid purpura |
| 06/09/2010 | CN101112486B Chinese traditional medicine composition for treating mammitis |
| 06/09/2010 | CN101104054B Method for preparing oral liquid for treating digestive system disease |
| 06/09/2010 | CN101095886B Chinese traditional medicine for treating heart neurosis and method for preparing the same |
| 06/09/2010 | CN101088554B Psoriasis treating Chinese medicine composition and its preparation process |
| 06/09/2010 | CN101057912B Medicine for treating hepatitis and cirrhosis ascites and its preparation method |
| 06/09/2010 | CN101057880B Traditional Chinese medicine for treating fracture and its preparation method |
| 06/09/2010 | CN101028489B Prescription for treating wart and its production |
| 06/09/2010 | CN100998666B Oral traditional Chinese medicine for treating trifacial neuralgia of cold-condensing and blood-stasis type |
| 06/08/2010 | US7732488 Marine oil derived ethyl ester of eicosapentaenoic acid and docosahexaenoic acid, with specified reduced levels of brominated flame retardants; not a health supplement; treat hypertriglyceridaemia |
| 06/08/2010 | US7732397 Use of cardiotrophin in liver diseases |
| 06/08/2010 | US7732203 Method for transdifferentiating mesenchymal stem cells into neuronal cells |
| 06/08/2010 | US7732201 neural cells comprising a neuroblast and a nestin-positive neural cell; for treating neuronal disorders |
| 06/08/2010 | US7732200 Using chondroitin sulfate proteoglycan (CSPG)-degrading enzymes mixture to propagate nervous system tissue in culture for use as tissue targeted tools in treatment of brain and neurodegenerative disorders |
| 06/08/2010 | US7732199 Generating cardiomyocytes from primate pluripotent stem cells via incubation in tissues which demonstrate spontaneous contraction, culture, separate and recover fractions which express cardiac marker proteins |
| 06/08/2010 | US7732190 Mixture comprising a first functionalized polymer in a first buffer; a second buffer at approximately physiological osmolality; a second functionalized polymer, a substance having at least one cell-adhesion site combined with the first mixture |
| 06/08/2010 | US7732188 Protozoan strains of reduced virulence and use thereof |
| 06/08/2010 | US7732129 use of low-medium perfusion rates in an attached cell culture system to provide for improved yields; improved Ad-p53 production with cells grown in serum-free conditions; offers scalability, validatability and virus purity comparable to that achieved using CsCl gradient ultracentrifugation |
| 06/08/2010 | US7731974 a mutant rhabdovirus having one or more mutation in a gene encoding a protein involved in blocking nuclear transport of mRNA or protein in an infected cells; capable of triggering the anti-viral systems of normal host cells; anticarcinogenic agent; vaccine adjuvant, vaccine vector |
| 06/08/2010 | US7731969 Methods for developing and producing antigen-specific antibody-producing cells |
| 06/08/2010 | US7731953 inducing proliferation of CD4+ T cells using human thymic stromal derived lymphopoietin (TSLP) polypeptide; asthma or rhino-conjunctivitis |
| 06/08/2010 | US7731951 Viruses for the treatment of cellular proliferative disorders |
| 06/08/2010 | US7731950 Attack of tumor cells with missing, low or aberrant MHC expression by combining non MHC-restricted T-cells/NK-cells and MHC-restricted cells |
| 06/08/2010 | CA2423960C Separation of cresol from mares' urine |
| 06/08/2010 | CA2266342C Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
| 06/08/2010 | CA2251624C Method for removal of psoralens from biological fluids |
| 06/08/2010 | CA2210956C Method for preparing a recombinant adenovirus genome |
| 06/03/2010 | WO2010062905A2 Lateral ventricle cell compositions and use for treating neural degenerative diseases |
| 06/03/2010 | WO2010062122A2 Composition for preventing or treating artherosclerosis |
| 06/03/2010 | WO2010061930A1 IMMUNOTHERAPEUTIC METHOD USING ALLO-CELLS WHICH CO-EXPRESS CD1d AND TARGET ANTIGEN |
| 06/03/2010 | WO2010061919A1 Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof |
| 06/03/2010 | WO2010061881A1 Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis c virus |
| 06/03/2010 | WO2010061877A1 Mineral absorption improver, and method for improving absorption of minerals |
| 06/03/2010 | WO2010061781A1 Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same |
| 06/03/2010 | WO2010061474A1 Connecting magnetic element, connecting magnetic element manufacturing method, connecting magnetic element injecting device, connecting magnetic element injection control system, magnetic field control device, and connecting magnetic element injection control method |
| 06/03/2010 | WO2010061030A1 Isolation of multipotent hypophysary cells and in vitro differentiation thereof |
| 06/03/2010 | WO2010060928A2 Compositions for the treatment of ischemic tissue damage |
| 06/03/2010 | WO2010060722A1 A nutritional composition comprising probiotics and improving sleep patterns |
| 06/03/2010 | WO2010060200A1 Bacteriophage compositions for treatment of bacterial infections |
| 06/03/2010 | US20100137835 Deployment system for myocardial cellular material |
| 06/03/2010 | US20100137811 Cell handling device, tissue regeneration composition, and tissue regeneration method |
| 06/03/2010 | US20100137198 Pharmaceutical composition for topical application |
| 06/03/2010 | US20100136668 Systems and methods for isolating and using clinically safe adipose derived regenerative cells |
| 06/03/2010 | US20100136662 Endotoxin binding by lactic acid bacteria and bifidobacteria |
| 06/03/2010 | US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/03/2010 | US20100136120 Compositions and methods for forming and strengthening bone |
| 06/03/2010 | US20100136114 De novo formation and regeneration of vascularized tissue from tissue progenitor cells and vascular progentitor cells |
| 06/03/2010 | US20100136100 Removal promoters and inhibitor for apoptosis cells in vivo |
| 06/03/2010 | US20100136087 Composition for Promoting Cartilage Formation or Repair Comprising a NELL Gene Product and Method of Treating Cartilage-Related Conditions Using Such Composition |
| 06/03/2010 | US20100136082 In situ system for intra-articular chondral and osseous tissue repair |
| 06/03/2010 | US20100136081 Hyaluronic acid derivative and neural stem cells for sci and pnt regeneration |
| 06/03/2010 | US20100136061 Light-mediated anti-cell proliferative compositions and methods |
| 06/03/2010 | US20100136056 Novel insertion sites in pox vectors |
| 06/03/2010 | US20100136054 Flavivirus ns1 subunit vaccine |
| 06/03/2010 | US20100135994 Hiv vaccine based on targeting maximized gag and nef to dendritic cells |
| 06/03/2010 | US20100135985 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them an uses thereof |
| 06/03/2010 | US20100135976 Adsorption device |
| 06/03/2010 | US20100135974 Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease |
| 06/03/2010 | US20100135970 Methods for Reprogramming Adult Somatic Cells and Uses Thereof |
| 06/03/2010 | US20100135969 Method of treating cancer using platelet releasate |
| 06/03/2010 | US20100135968 Oligodendrocyte Production From Multipotent Neural Stem Cells |
| 06/03/2010 | US20100135967 Cultured cartilage/bone cells/tissue, method of generating same and uses thereof |
| 06/03/2010 | US20100135966 Agents for treating flaviviridae infections |
| 06/03/2010 | US20100135965 Method of chondrogenic differentiation from mesenchymal stem cell, and composition comprising chondrogenic cell differentiated using the method to treat disease caused by cartilage damage |
| 06/03/2010 | US20100135963 Use of pax4 in pancreatic cell proliferation |
| 06/03/2010 | US20100135961 Live bacterial vaccines resistant to carbon dioxide (co2), acidic ph and/or osmolarity for viral infection prophylaxis or treatment |
| 06/03/2010 | US20100135902 Papillomavirus pseudoviruses for detection and therapy of tumors |
| 06/03/2010 | US20100132722 Magnetic cell and method of using the same |
| 06/03/2010 | CA2744909A1 Bacteriophage compositions for treatment of bacterial infections |
| 06/03/2010 | CA2744289A1 Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same |
| 06/03/2010 | CA2742476A1 A nutritional composition comprising probiotics and improving sleep patterns |
| 06/02/2010 | EP2191845A1 Immunology significant herpes simplex virus antigens and methods for using same |
| 06/02/2010 | EP2191836A1 Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
| 06/02/2010 | EP2191835A1 Therapeutic and prophylactic agents for arthritis |
| 06/02/2010 | EP2190444A2 Pharmaceutical composition for preventing and treating cell proliferative disease comprising mixture of feather of birds and scale of fish as an active ingredient |
| 06/02/2010 | EP2190438A2 Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
| 06/02/2010 | EP2190403A1 Use of 2,2'-cyclolignanes for inducing, restoring or stimulating the pigmentation of the skin, hair or hairs |
| 06/02/2010 | EP1697521B1 Multi plasmid system for the production of influenza virus |
| 06/02/2010 | EP1549155B1 Food additive and/or drinking water additive for domestic animals |
| 06/02/2010 | EP1539812B1 Osteoinductive biomaterials |
| 06/02/2010 | EP1066050B2 Application of hsp70 proteins |
| 06/02/2010 | CN201492711U Cordyceps sinensis tablet |
| 06/02/2010 | CN1994457B Swelling-relieving pain-stopping externally applied ointment |
| 06/02/2010 | CN1994433B Kidney-tonifying health product and preparation method thereof |
| 06/02/2010 | CN1988883B Scalp and hair-care composition |
| 06/02/2010 | CN1972698B Beta-hydroxy short to medium chain fatty acid polymer |
| 06/02/2010 | CN1291231B Human telomerase catalytic subunit |
| 06/02/2010 | CN101717767A Tissue engineering microencapsulated hepatocyte and preparation and application thereof |
| 06/02/2010 | CN101717754A Enterovirus type 71 and use thereof |
| 06/02/2010 | CN101717711A Five-step wind-dispelling wine and preparation method thereof |
| 06/02/2010 | CN101716357A Virus inactivation method of extracting solution of human placenta |
| 06/02/2010 | CN101716333A Preparation method of pupa glycoprotein immunoregulation preparation |
| 06/02/2010 | CN101716330A Traditional Chinese medicine composition for treating angina disease and preparation method thereof |
| 06/02/2010 | CN101716329A Syrup for nourishing yin and clearing lung-heat |